Lisa Wootten suffered monthly seizures that were chalked up to nerves — until doctors discovered the devastating cause of her ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio DENVER — Primary generalized tonic-clonic ...
The FDA also approved Vimpat Injection for use in pediatric patients 4 years of age and older. The Food and Drug Administration (FDA) has approved Vimpat ® (lacosamide; UCB) as adjunctive therapy in ...
A phase 3 study assessing the use pregabalin as adjunctive therapy for epilepsy patients 5 to 65 years of age with primary generalized tonic-clonic (PGTC) seizures did not meet its primary endpoint to ...
--UCB, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved VIMPAT ® CV as adjunctive therapy in the treatment of primary generalized tonic-clonic ...
LONDON--(BUSINESS WIRE)-- LivaNova PLC (LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with drug-resistant ...
TOKYO, May 13, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has received approval in China for the additional indication of its in-house discovered antiepileptic drug (AED) ...
ATLANTA, June 24, 2024 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that Epilepsia published findings from a comprehensive scoping review examining the efficacy of FINTEPLA ...
Early Infantile Epileptic Encephalopathy (EIEE) or Ohtahara syndrome is a severe and congenital seizure disorder that affects neonates within the first three months of life, and often within the first ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback